Stocks · Healthcare · Biotechnology
Insmed Incorporated INSM
$111.12 +2.33% Close, Oct 2, 2026 · NASDAQ · Market cap $24.09B
Strong growthWeak trend
Next earnings report: Oct 29, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Revenue over the last four quarters was $1.14B, up 185.8% from a year earlier, accelerating from 115.1% a quarter earlier.
- Operating margin widened to -71.9% from -252.4% a year earlier.
- The diluted share count rose 14.8% in a year.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Top 7%
- Revenue growth, 3-year CAGRTop 19%
- Revenue growth accelerationTop 4%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalBottom 26%
- Gross marginTop 27%
- Operating marginBottom 33%
- Accruals (lower is better)Bottom 40%
- Interest coverBottom 33%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldTop 41%
- Free-cash-flow yieldTop 48%
- EBITDA / enterprise valueTop 47%
- Sales / enterprise valueBottom 19%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthBottom 27%
- 6-month returnBottom 15%
- 1-year return vs S&P 500Bottom 26%
- Distance from 52-week highBottom 31%
- Trend checklist (0–4)Bottom 14%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersTop 40%
- Consecutive EPS beatsTop 35%
- Share of analysts rating BuyTop 21%
- Upside to consensus price targetTop 44%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Bottom 27%
- Maximum drawdown, 3 yearsTop 30%
- Beta vs S&P 500 (lower is better)Top 38%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | 115.1% | 185.8% | ↑ |
| Gross margin | 75.7% | 83.3% | ↑ |
| Operating margin | -252.4% | -71.9% | ↑ |
| FCF margin | -218.2% | -73.6% | ↑ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | 185.8% | 115.1% | ↑ | Top 7% |
| Gross margin | 83.3% | 75.7% | ↑ | Top 27% |
| Operating margin | -71.9% | -252.4% | ↑ | Bottom 33% |
| Net margin | -76.9% | -259.8% | ↑ | — |
| Free-cash-flow margin | -73.6% | -218.2% | ↑ | — |
| Return on invested capital | -48.8% | — | Bottom 26% | |
| Revenue growth, 3-year CAGR | 35.2% | — | Top 19% |
Quality of earnings and balance sheet
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -4.6%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 10.4%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- +105.5 pp
- Interest cover (operating income / interest)How many times operating profit covers interest.
- -10.1×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- -0.53%
- Shareholder yield
- -0.53%
- Share count change, 1 year
- +14.8%
- Share count change, 3-year CAGR
- +16.5%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Aug 6, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 2
- Beats in the last 8 reports
- 2 of 8
- Average EPS surprise, last 4
- +9.2%
- Average 2-day reaction, last 8
- +2.9%
- Positive 20 days after report
- 5 of 8
Analysts
- Consensus price target
- $197.00
- Target vs current price
- +77.3%
- Analysts with a rating
- 35
- Share rating Buy or Strong Buy
- 94%
- Consensus rating
- Buy
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Aug 6, 2026 | +91.1% | +33.9% | +33.6% | +27.9% | — |
| May 7, 2026 | +21.1% | -23.4% | -13.9% | -23.5% | -28.2% |
| Feb 19, 2026 | -43.9% | +6.5% | -1.7% | -5.6% | -23.5% |
| Oct 30, 2025 | -31.6% | +16.3% | +11.9% | +22.5% | -2.6% |
| Aug 7, 2025 | -30.8% | -1.8% | +10.4% | +28.1% | +74.6% |
| May 8, 2025 | -6.0% | -3.9% | -3.9% | +6.5% | +62.9% |
| Feb 20, 2025 | -12.8% | -0.3% | -6.8% | -5.8% | -19.8% |
| Oct 31, 2024 | -5.8% | -4.3% | +3.6% | +7.9% | +11.0% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Aug 6, 2026 | -$0.06 | -$0.67 | +91.1% | $425.5M |
| May 7, 2026 | -$0.76 | -$0.96 | +21.1% | $306.0M |
| Feb 19, 2026 | -$1.54 | -$1.07 | -43.9% | $263.8M |
| Oct 30, 2025 | -$1.75 | -$1.33 | -31.6% | $142.3M |
| Aug 7, 2025 | -$1.70 | -$1.30 | -30.8% | $107.4M |
| May 8, 2025 | -$1.42 | -$1.34 | -6.0% | $92.8M |
| Feb 20, 2025 | -$1.32 | -$1.17 | -12.8% | $104.4M |
| Oct 31, 2024 | -$1.27 | -$1.20 | -5.8% | $93.4M |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| EV / Sales | 21.20× | — | — | Bottom 19% |
| Free-cash-flow yield | -3.48% | — | — | Top 48% |
| Earnings yield | -3.70% | — | — | Top 41% |
Technical state
Trend checklist
- ✗ Price above 20-day average
- ✗ Price above 50-day average
- ✗ Price above 200-day average
- ✗ 50-day average above 200-day
- ✗ MACD histogram positive
Trend quality
- Days above the 50-day average
- 0
- Days above the 200-day average
- 0
- 50-day average slope (20 days)
- +4.0%
- 200-day average slope (20 days)
- -5.7%
- Distance from 50-day average
- -7.3%
- Distance from 200-day average
- -16.5%
- RSI (14)
- 37.8
- Relative volume
- 1.89×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 70.0%
- Volatility vs own 5-year history
- 85th percentile · High for this stock
- Beta vs S&P 500 (2 years, weekly)
- 0.91
- Correlation with S&P 500
- 0.24
- Current drawdown from 1-year high
- -47.4%
- Maximum drawdown, 3 years
- -56.5%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Feb 8, 2021 | Mar 22, 2023 | -63.3% | 533 days | 297 days (May 28, 2024) |
| Dec 1, 2025 | Jun 10, 2026 | -56.5% | 131 days | Not yet recovered |
| Feb 19, 2025 | Apr 10, 2025 | -22.7% | 36 days | 41 days (Jun 10, 2025) |
| Oct 20, 2020 | Nov 2, 2020 | -18.3% | 9 days | 11 days (Nov 17, 2020) |
| Dec 15, 2020 | Jan 11, 2021 | -18.1% | 17 days | 7 days (Jan 21, 2021) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $24.09B
- EPS, diluted (TTM)
- -$4.11
- Revenue (TTM)
- $1.14B
- 52-week range
- $90.39 – $212.75
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $188.5M | $245.4M | $305.2M | $363.7M | $606.4M |
| Gross profit | $144.3M | $190.2M | $239.6M | $278.0M | $481.5M |
| Operating income | -$375.1M | -$457.3M | -$709.6M | -$878.3M | -$1.18B |
| Net income | -$434.7M | -$481.5M | -$749.6M | -$913.8M | -$1.28B |
| EPS (diluted) | -$3.88 | -$3.91 | -$5.34 | -$5.57 | -$6.41 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $93.4M | $104.4M | $92.8M | $107.4M | $142.3M | $263.8M | $306.0M | $425.5M |
| Net income | -$220.5M | -$235.5M | -$256.6M | -$321.7M | -$370.0M | -$328.5M | -$163.6M | -$13.2M |
| EPS (diluted) | -$1.27 | -$1.32 | -$1.42 | -$1.70 | -$1.75 | -$1.54 | -$0.76 | -$0.06 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | -$363.3M | -$400.4M | -$536.2M | -$683.9M | -$935.0M |
| Capital expenditure | -$7.3M | -$9.9M | -$13.3M | -$21.9M | -$32.6M |
| Free cash flow | -$370.6M | -$410.3M | -$549.5M | -$705.8M | -$967.6M |
| Dividends paid | $0 | $0 | $0 | $0 | $0 |
| Net share buybacks | $269.9M | $292.2M | $152.5M | $1.08B | $959.0M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $1.16B
- Total assets
- $2.10B
- Total liabilities
- $1.35B
- Total debt
- $579.9M
- Net debt
- $35.1M
- Shareholders’ equity
- $757.5M
As of Jun 30, 2026 (filed Aug 6, 2026).
Short interest
- Shares sold short
- 10,802,070
- Days to cover
- 5.27
- Change vs previous report
- -5.6%
FINRA short interest, settlement date Sep 15, 2026.
Stock splits
- Mar 3, 2011
- 1-for-10
- Jul 31, 2000
- 1-for-4